MPS, Type 1 (click to watch APHL webinar series)

• Implementation Considerations
• Clinical Aspects
• Overview of Available Screening Methods

Spinal Muscular Atrophy

• Emerging Therapies and Challenges in Spinal Muscular Atrophy

Adrenoleukodystrophy Symposium Talks (click to watch via Youtube)

• Diagnostic Testing and History of Adrenoleukodystrophy – Ann Moser, BA
• ALD Management and Treatment – Gerald Raymond, MD
• Genetic Counseling Considerations of ALD Newborn Screening and Differential Diagnoses – Beth Vogel
• New York State ALD Laboratory Protocol – Joseph Orsini, Ph.D.
• Protocol for Diagnosis and Management Guidelines – Sarah Bradley, MS, CGC
• Parent and Patient Perspectives – Spenser Barsh
• Status of ALD Screening in New Jersey – Scott Shone, Ph.D.
• Parent and Patient Perspectives – Elisa Seeger
• Long-term Follow-up and Educational Materials Group Discussion – Beth Vogel, MS, CGC
• Review NYS ALD Outcomes – Michele Caggana, Sc.D, FACMG
• Status of ALD Screening in California – Bob Currier, Ph.D.

Pompe Disease and MPS1 (click to watch via Youtube)

• New York Newborn Screening Outcomes and Lab Method – Joseph Orsini, Ph.D.
• 2^ndTier Molecular Testing for Pompe Disease and MPSI – Michele Caggana, Sc.D., FACMG
• Implications of screening for conditions with a late-onset and long-term follow-up – Susan Berry, M.D.